Admission NT‐proBNP and outcomes in patients without history of heart failure hospitalized with COVID‐19
Abstract Aims We examined the value of N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) in patients admitted for coronavirus disease 2019 (COVID‐19) without prior history of heart failure (HF) or cardiomyopathy. Methods and results Retrospective cohort of consecutive adults (N = 679; median age...
Main Authors: | Jeanwoo Yoo, Prabhjot Grewal, Jessica Hotelling, Aikaterini Papamanoli, Kerry Cao, Simrat Dhaliwal, Robin Jacob, Azad Mojahedi, Michelle E. Bloom, Luis A. Marcos, Hal A. Skopicki, Andreas P. Kalogeropoulos |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-10-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.13548 |
Similar Items
-
NT-proBNP in Isolated Diastolic Dysfunction
by: Kenan İltümür, et al.
Published: (2005-01-01) -
Valor prognóstico dos peptídeos natriuréticos BNP e NT-proBNP na estratificação de risco dos pacientes com estenose aórtica grave
by: Marcelo Katz
Published: (2009) -
Valor prognóstico dos peptídeos natriuréticos BNP e NT-proBNP na estratificação de risco dos pacientes com estenose aórtica grave
by: Katz, Marcelo
Published: (2009) -
The Role of NT-proBNP in the Diagnosis of Ventricular Arrhythmias in Patients with Systemic
by: Lucian MURESAN, et al.
Published: (2017-06-01) -
Significance of NT-proBNP and High-sensitivity Troponin in Friedreich Ataxia
by: Lise Legrand, et al.
Published: (2020-05-01)